Please use one of the following formats to cite this article in your essay, paper or report: APA PhoreMost. (2025, May 12). PhoreMost makes key appointments to Board to advance development of next ...

“Cambridge is a one-of-a-kind innovation hub where great ideas ... networking events and access to investors.” PhoreMost is pioneering new technologies to help create treatments for diseases which ...

Last month, Cambridge biopharma company PhoreMost added $12 million to its Series B financing, bringing the total raised to over $50m. The additional investment was led by Parkwalk Advisors with ...

Spin-outs from Cambridge University include Mission Therapeutics, Cambridge Epigenetix, XO1 Therapeutics, Z-factor, Phoremost, Predictimmue and Polyprox; XO1 was sold to Janssen for an undisclosed sum ...

Cambridge biopharma company PhoreMost, has added $12 million to its Series B financing, bringing the total raised to over $50m. The additional investment was led by Parkwalk Advisors, the largest ...

CAMBRIDGE, England--(BUSINESS WIRE)--PhoreMost Ltd., a leading UK biopharmaceutical company unlocking the next generation of drug targets, today announced the introduction of GlueSEEKER™.

The mid-priced Cambridge Audio Melomania M100 give more costly noise-canceling earbuds a run for the money, and are among the best wireless earbuds I've heard. Why you can trust Tom's Guide Our ...

PhoreMost's adoption of CDD Vault is the latest in a series of strategic moves the company has made to advance its drug discovery processes. In the last year, the Cambridge, UK based company has ...

Building on an R&D tie-up with an Indian stem cell institution last year, UK biotech PhoreMost has begun a collaboration with Japan’s Otsuka working on several gene therapy projects. Cambridge ...